Lee Hwan-sung, chairman of Cellumed, adopts Lee Kyung-soo, CEO, as joint heir... begins management succession
Predicted impact: Medium
Chairman adopting CEO as heir begins succession; control-related but no share or size data given.
Drgem디알젬
263690 · KOSDAQ · ₩263690 · 디알젬
₩4,850▼ ₩20 (0.41%)End-of-day · Oct 29, 2026 · End-of-day prices.
Price · 1Y −12.61%
- Market cap
- ₩55B
- Enterprise value
- ₩50B
- P/E
- 4.5×
- P/B
- 0.6×
- Dividend yield
- 3.7%
- ROE
- 12.5%
- Net margin
- 11.2%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−23.3% from the high
₩4,605Today: ₩4,775 – ₩4,900₩6,320
Returns
- 1W−4.0%
- 1M−4.9%
- 3M+0.4%
- 6M−15.8%
- YTD−9.2%
- 1Y−12.6%
- Volume today
- 7,672
- 0.6× the 20-day average
- Traded today
- ₩37M
- Listed shares
- 11,325,610
- EPS (12 months)
- ₩1,084
- Earnings yield 22.4%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 38 of 100 (50 is a normal day for this stock).
- MomentumFlat-4% over the last month; the price is below its 20-day average.
- News impactSome1 news items and filings in two weeks; 0 rated high impact, 1 medium.
Signals describe activity, not recommendations. Not financial advice.
Drgem stock overview
Drgem (디알젬, KRX: 263690) is listed on KOSDAQ, in the Medical & precision devices sector. The company was founded in 2003 and researches, develops, manufactures and sells diagnostic X-ray imaging equipment used by hospitals and clinics to examine patients. Its shares closed at ₩4,850 on Oct 29, 2026, down 0.41% on the day, giving it a market value of ₩55B.
Key facts
- Market cap
- ₩55B
- Sector
- Medical & precision devices
- Latest price change
- −0.41%
- As of
- Oct 29, 2026
- Main business
- The company was founded in 2003 and researches, develops, manufactures and sells diagnostic X-ray imaging equipment used by hospitals and clinics to examine patients.
Quick answers about Drgem
- What does Drgem do?
- The company was founded in 2003 and researches, develops, manufactures and sells diagnostic X-ray imaging equipment used by hospitals and clinics to examine patients. Its products include analog and digital X-ray systems, systems that upgrade analog equipment to digital, and core components such as generators, tubes, collimators and imaging software. It sells through about 250 dealers in roughly 120 countries worldwide.
- What is the market cap of Drgem?
- The market capitalisation of Drgem was ₩55B at the close on Oct 29, 2026.
- Who are the largest shareholders of Drgem?
- According to the latest official filings, the largest reported holders are Park Jeong-byeong (43.08%, as of Sep 19, 2025).
- When is the next earnings report from Drgem?
- Korean companies rarely announce results dates in advance. Based on when Drgem filed the same report in past years, its next 3q results is expected around Nov 13, 2026.
Company profile
The company was founded in 2003 and researches, develops, manufactures and sells diagnostic X-ray imaging equipment used by hospitals and clinics to examine patients. Its products include analog and digital X-ray systems, systems that upgrade analog equipment to digital, and core components such as generators, tubes, collimators and imaging software. It sells through about 250 dealers in roughly 120 countries worldwide.
Written by AI from the company's latest annual report.
- Korean name
- 디알젬
- Themes
- Medical devices
- CEO
- 박정병
- Founded
- Sep 2003
- Listed
- Nov 2018
- Listed shares
- 11,325,610
- Fiscal year ends
- Month 12
- Website
- www.drgemhealthcare.com
Similar companies
- TSE131290 · ₩2.9T₩260,500−5.27%
- Kctech281820 · ₩1.9T₩97,500+2.09%
- Classys214150 · ₩1.7T₩26,800−0.74%
- Park Systems140860 · ₩1.6T₩228,500−0.44%
- DI003160 · ₩1.2T₩43,500+0.46%
- Curiox Biosystems445680 · ₩1T₩60,600−2.88%
- LivsMed491000 · ₩1T₩40,450−7.33%
- Seers458870 · ₩907B₩23,650−3.86%
Recent news
Recent filings
See all- Half-year report (Jun 2026)Aug 14, 2026
- Major sales or supply contractJul 22, 2026
- Quarterly report (Mar 2026)May 14, 2026
- Corporate value-up planMar 24, 2026
- Annual general meeting resultsMar 23, 2026
Titles in Korean until English translations are added.
Also known as: Drgem / 디알젬 / 263690 / KRX:263690
Source: KRX statistical information